Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Coronavirus Clash: Global Pharma Scrambles In Locking Down World

Managing Change In Unprecedented Crisis

Executive Summary

A former pharma executive shares views with Scrip about the coronavirus in China, the challenges facing corporations and individuals in a rapidly changing world and coming threats that could potentially cause even more damage than the pandemic.

You may also be interested in...



From Biogen To Bayer: Coronavirus A Stress Test For Pharma

When a global pandemic hits and local rules over personal movement are highly fluid and constantly updated, two pharma firms with a global footprint have faced unprecedented tests.

Volume-Based Purchasing Looms Larger In Post-Coronavirus China

China's centralized procurement scheme, if further expanded after causing the prices of 32 drugs to be cut by more than half in the latest round, will leave companies no room to breathe easy amid the already devastating coronavirus outbreak, analysts say.

As China Rushes Medical Supplies To World, Quality Issues Resurface

As China is poised to supply medical products to fight the coronavirus around the world, a battle to banish its image of poor product quality is on.

Topics

Related Companies

UsernamePublicRestriction

Register

SC141906

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel